HBEGF抗体HBEGF兔多抗抗体Proheparin bi
nding EGF like growth factor antibody抗体HBEGF Antibody, FITC conjugated抗体- ￥880 - 1320
- CUSABIO
- CN
- CSB-PA857429LC01HU
- 2025年07月15日
- /
- Rabbit
- Human
企业认证
相关产品推荐更多 >
KDELR2抗体KDELR2一抗抗体KDEL receptor 2抗体KDELR2 Antibody抗体
￥880
NDUFS4抗体NDUFS4兔多抗抗体NDUS4_HUMAN antibody抗体NDUFS4 Antibody, HRP conjugated抗体
￥880POLDIP2抗体POLDIP2兔多抗抗体Polymerase delta-interacting protein 2 antibody抗体POLDIP2 Antibody, HRP conjugated抗体
￥880
UBR1抗体UBR1兔多抗抗体UBR1_HUMAN antibody抗体UBR1 Antibody, HRP conjugated抗体
￥880
MLYCD抗体MLYCD一抗抗体Mlycd antibody抗体MLYCD Antibody抗体
￥3900
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human Proheparin-binding EGF-like growth factor protein (63-148AA)
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性：
Polyclonal
- 标记物：
FITC
- 适应物种：
Human
- 保质期：
6个月
- 抗原来源：
Homo sapiens (Human)
- 目录编号：
Q99075
- 级别：
优
- 库存：
200
- 供应商：
武汉华美生物工程有限公司
- 宿主：
Rabbit
- 应用范围：
/
- 浓度：
>95%,Protein G purified
- 靶点：
HBEGF
- 抗体英文名：
HBEGF Antibody, FITC conjugated
- 抗体名：
Proheparin binding EGF like growth factor antibody
- 规格：
100μg/50μg
| 规格： | 100μg | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 50μg | 产品价格： | ￥880.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
功能
Growth factor that mediates its effects via EGFR, ERBB2 and ERBB4. Required for normal cardiac valve formation and normal heart function. Promotes smooth muscle cell proliferation. May be involved in macrophage-mediated cellular proliferation. It is mitogenic for fibroblasts, but not endothelial cells. It is able to bind EGF receptor/EGFR with higher affinity than EGF itself and is a far more potent mitogen for smooth muscle cells than EGF. Also acts as a diphtheria toxin receptor.风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验factor (EGF) receptor also stimulates second-messenger systems that involve the heterotrimeric G proteins. For instance, in the heart EGF increases contractility and heart rate by elevating cellular cyclic adenosine monophosphate (cAMP) levels
Tyrosine Kinase Inhibitors Against EGF Receptor-Positive Malignancies
epidermal growth factor receptor (EGFR) (1 –6 ), Janus kinases (JAKs) (7 –13 ), Bruton’s tyrosine kinase (BTK) (14 –16 ), platelet-derived growth factor (PDGF) (17 ), protein kinase C (PKC) (18 –24 ), Lck (25 , 26 ), Trk (27 –30
The binding of ligand to the extracellular domain of the epidermal growth factor (EGF) receptor is the event that initiates the activation of the tyrosine kinase activity present on the cytoplasmic domain. This activation leads
技术资料暂无技术资料 索取技术资料
